2,062
Views
4
CrossRef citations to date
0
Altmetric
Bedside-to-Bench Report

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma

, , &
Pages 1097-1104 | Received 21 Sep 2019, Accepted 22 Sep 2020, Published online: 05 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (4)